After more than 10 years treating patients, Karl joined the pharmaceutical and biotech industry and held positions of increasing responsibility in drug, biologics and vaccines development and medical affairs. He has previously worked at SmithKlineBeecham (Harlow, UK), Bayer (Slough, UK), Pharming (Leiden) and Baxter BioScience (Vienna, Austria), where he was Therapeutic Area Head for Immunology and Critical Care. He went on to become Director of Clinical Development and Safety Assessments for Philip Morris (Neuchatel, Switzerland), and then joined Swissmedic (Bern, Switzerland), the regulatory authority in Switzerland, as Deputy Head, Division Clinical Review. Pierre Courteille, Chief Commercial Officer & Vice President Business Development